MLTX logo

MoonLake Immunotherapeutics (MLTX) Debt To Equity Ratio

Annual Debt To Equity:

0.010.00(0.00%)
December 31, 2024

Summary

  • As of today, MLTX annual debt to equity ratio is 0.01, unchanged on December 31, 2024.
  • During the last 3 years, MLTX annual debt to equity has risen by +1.30 (+100.78%).
  • MLTX annual debt to equity is now at all-time high.

Performance

MLTX Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXfinancial health metrics

Quarterly Debt To Equity:

0.21+0.02(+10.53%)
June 30, 2025

Summary

  • As of today, MLTX quarterly debt to equity ratio is 0.21, with the most recent change of +0.02 (+10.53%) on June 30, 2025.
  • Over the past year, MLTX quarterly debt to equity has increased by +0.20 (+2000.00%).
  • MLTX quarterly debt to equity is now -92.11% below its all-time high of 2.66, reached on September 1, 2020.

Performance

MLTX Quarterly Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXfinancial health metrics

Debt To Equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

MLTX Debt To Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year0.0%+2000.0%
3Y3 Years+100.8%+100.0%
5Y5 Years+100.0%-92.1%

MLTX Debt To Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+100.8%at high>+9999.0%
5Y5-Yearat high+100.8%-92.1%+116.3%
All-TimeAll-Timeat high+100.8%-92.1%+116.3%

MLTX Debt To Equity History

DateAnnualQuarterly
Jun 2025
-
0.21(+10.5%)
Mar 2025
-
0.19(+1800.0%)
Dec 2024
0.01(0.0%)
0.01(0.0%)
Sep 2024
-
0.01(0.0%)
Jun 2024
-
0.01(0.0%)
Mar 2024
-
0.01(0.0%)
Dec 2023
0.01(0.0%)
0.01(>+9900.0%)
Sep 2023
-
0.00(0.0%)
Jun 2023
-
0.00(-100.0%)
Mar 2023
-
0.01(0.0%)
DateAnnualQuarterly
Dec 2022
0.01(+100.8%)
0.01(>+9900.0%)
Sep 2022
-
0.00(0.0%)
Jun 2022
-
0.00(-100.0%)
Mar 2022
-
0.62(+148.1%)
Dec 2021
-1.29(>-9900.0%)
-1.29(>-9900.0%)
Sep 2021
-
0.00(0.0%)
Jun 2021
-
0.00(0.0%)
Mar 2021
-
0.00(0.0%)
Dec 2020
0.00
0.00(-100.0%)
Sep 2020
-
2.66

FAQ

  • What is MoonLake Immunotherapeutics annual debt to equity ratio?
  • What is the all-time high annual debt to equity for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics annual debt to equity year-on-year change?
  • What is MoonLake Immunotherapeutics quarterly debt to equity ratio?
  • What is the all-time high quarterly debt to equity for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics quarterly debt to equity year-on-year change?

What is MoonLake Immunotherapeutics annual debt to equity ratio?

The current annual debt to equity of MLTX is 0.01

What is the all-time high annual debt to equity for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high annual debt to equity ratio is 0.01

What is MoonLake Immunotherapeutics annual debt to equity year-on-year change?

Over the past year, MLTX annual debt to equity ratio has changed by 0.00 (0.00%)

What is MoonLake Immunotherapeutics quarterly debt to equity ratio?

The current quarterly debt to equity of MLTX is 0.21

What is the all-time high quarterly debt to equity for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high quarterly debt to equity ratio is 2.66

What is MoonLake Immunotherapeutics quarterly debt to equity year-on-year change?

Over the past year, MLTX quarterly debt to equity ratio has changed by +0.20 (+2000.00%)
On this page